Stay updated with breaking news from Mapping Catheter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Cortex announced today the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in late October 2023. The international,...
Acutus Medical Inc AFIB announced a realignment of resources and corporate restructuring to become a contract manufacturing business that could generate…
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i today announced the U.S. launch of the OPTRELL™ Mapping Catheter with TRUEref™ Technology powered by the CARTO® 3 System. The OPTRELL™ Mapping Catheter is a high-density diagnostic catheter, with small ...
Presentations include data on pulsed field ablation (PFA), disparities in atrial fibrillation (AFib) management, role of mapping and digital technologies in advancing cardiac arrhythmia treatment and real-world evidence informing treatment pathways
The OCTARAY Mapping Catheter with TRUEref Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac arrhythmias